CA2987919A1 - Fluorescence histo-tomography (fht) systems and methods - Google Patents
Fluorescence histo-tomography (fht) systems and methods Download PDFInfo
- Publication number
- CA2987919A1 CA2987919A1 CA2987919A CA2987919A CA2987919A1 CA 2987919 A1 CA2987919 A1 CA 2987919A1 CA 2987919 A CA2987919 A CA 2987919A CA 2987919 A CA2987919 A CA 2987919A CA 2987919 A1 CA2987919 A1 CA 2987919A1
- Authority
- CA
- Canada
- Prior art keywords
- fluorescence
- white light
- fht
- chamber
- image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003325 tomography Methods 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 98
- 230000000717 retained effect Effects 0.000 claims abstract description 11
- 238000003384 imaging method Methods 0.000 claims description 97
- 238000002073 fluorescence micrograph Methods 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 23
- 238000005286 illumination Methods 0.000 claims description 21
- 238000012545 processing Methods 0.000 claims description 13
- 230000007246 mechanism Effects 0.000 claims description 12
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 83
- 239000007789 gas Substances 0.000 description 26
- 238000012230 antisense oligonucleotides Methods 0.000 description 21
- 238000000799 fluorescence microscopy Methods 0.000 description 20
- 239000000074 antisense oligonucleotide Substances 0.000 description 18
- 108091034117 Oligonucleotide Proteins 0.000 description 16
- 238000005520 cutting process Methods 0.000 description 14
- 238000003860 storage Methods 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- OFBIFZUFASYYRE-GKTGUEEDSA-N ethyl 8-fluoranyl-5-methyl-6-oxo-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate Chemical compound C1N(C)C(=O)C2=CC([18F])=CC=C2N2C=NC(C(=O)OCC)=C21 OFBIFZUFASYYRE-GKTGUEEDSA-N 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 238000007913 intrathecal administration Methods 0.000 description 9
- 102000017696 GABRA1 Human genes 0.000 description 8
- 101000893331 Homo sapiens Gamma-aminobutyric acid receptor subunit alpha-1 Proteins 0.000 description 8
- 230000005284 excitation Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 108091006146 Channels Proteins 0.000 description 7
- 108091007767 MALAT1 Proteins 0.000 description 7
- 238000004590 computer program Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 210000005013 brain tissue Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000003285 pharmacodynamic effect Effects 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 210000002330 subarachnoid space Anatomy 0.000 description 4
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 3
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 230000008499 blood brain barrier function Effects 0.000 description 3
- 210000001218 blood-brain barrier Anatomy 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 239000000700 radioactive tracer Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- MJKVTPMWOKAVMS-UHFFFAOYSA-N 3-hydroxy-1-benzopyran-2-one Chemical compound C1=CC=C2OC(=O)C(O)=CC2=C1 MJKVTPMWOKAVMS-UHFFFAOYSA-N 0.000 description 2
- WEJVZSAYICGDCK-UHFFFAOYSA-N Alexa Fluor 430 Chemical compound CC[NH+](CC)CC.CC1(C)C=C(CS([O-])(=O)=O)C2=CC=3C(C(F)(F)F)=CC(=O)OC=3C=C2N1CCCCCC(=O)ON1C(=O)CCC1=O WEJVZSAYICGDCK-UHFFFAOYSA-N 0.000 description 2
- WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 2
- ZAINTDRBUHCDPZ-UHFFFAOYSA-M Alexa Fluor 546 Chemical compound [H+].[Na+].CC1CC(C)(C)NC(C(=C2OC3=C(C4=NC(C)(C)CC(C)C4=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C(=C(Cl)C=1Cl)C(O)=O)=C(Cl)C=1SCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O ZAINTDRBUHCDPZ-UHFFFAOYSA-M 0.000 description 2
- 239000012114 Alexa Fluor 647 Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010004469 allophycocyanin Proteins 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 210000004227 basal ganglia Anatomy 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- HQCYVSPJIOJEGA-UHFFFAOYSA-N methoxycoumarin Chemical compound C1=CC=C2OC(=O)C(OC)=CC2=C1 HQCYVSPJIOJEGA-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000015927 pasta Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- QWZHDKGQKYEBKK-UHFFFAOYSA-N 3-aminochromen-2-one Chemical compound C1=CC=C2OC(=O)C(N)=CC2=C1 QWZHDKGQKYEBKK-UHFFFAOYSA-N 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 239000012109 Alexa Fluor 568 Substances 0.000 description 1
- 239000012110 Alexa Fluor 594 Substances 0.000 description 1
- 239000012112 Alexa Fluor 633 Substances 0.000 description 1
- 239000012115 Alexa Fluor 660 Substances 0.000 description 1
- 239000012116 Alexa Fluor 680 Substances 0.000 description 1
- 239000012117 Alexa Fluor 700 Substances 0.000 description 1
- 239000012118 Alexa Fluor 750 Substances 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- RURLVUZRUFHCJO-UHFFFAOYSA-N Chromomycin A3 Natural products COC(C1Cc2cc3cc(OC4CC(OC(=O)C)C(OC5CC(O)C(OC)C(C)O5)C(C)O4)c(C)c(O)c3c(O)c2C(=O)C1OC6CC(OC7CC(C)(O)C(OC(=O)C)C(C)O7)C(O)C(C)O6)C(=O)C(O)C(C)O RURLVUZRUFHCJO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 241000143637 Eleocharis confervoides Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 108090000839 GABA-A Receptors Proteins 0.000 description 1
- 102000004300 GABA-A Receptors Human genes 0.000 description 1
- 102220564757 Killer cell immunoglobulin-like receptor 2DS2_Y66F_mutation Human genes 0.000 description 1
- FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 description 1
- 241000078511 Microtome Species 0.000 description 1
- 238000000342 Monte Carlo simulation Methods 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- DPXHITFUCHFTKR-UHFFFAOYSA-L To-Pro-1 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 DPXHITFUCHFTKR-UHFFFAOYSA-L 0.000 description 1
- QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 108010021843 fluorescent protein 583 Proteins 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- -1 humidity) Chemical compound 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
- SUIPVTCEECPFIB-UHFFFAOYSA-N monochlorobimane Chemical compound ClCC1=C(C)C(=O)N2N1C(C)=C(C)C2=O SUIPVTCEECPFIB-UHFFFAOYSA-N 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 229960002378 oftasceine Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229960003171 plicamycin Drugs 0.000 description 1
- 230000007425 progressive decline Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/04—Devices for withdrawing samples in the solid state, e.g. by cutting
- G01N1/06—Devices for withdrawing samples in the solid state, e.g. by cutting providing a thin slice, e.g. microtome
Landscapes
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211930P | 2015-08-31 | 2015-08-31 | |
| US62/211,930 | 2015-08-31 | ||
| US15/158,928 US9799113B2 (en) | 2015-05-21 | 2016-05-19 | Multi-spectral three dimensional imaging system and method |
| US15/158,928 | 2016-05-19 | ||
| PCT/US2016/049708 WO2017040671A1 (en) | 2015-08-31 | 2016-08-31 | Fluorescence histo-tomography (fht) systems and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2987919A1 true CA2987919A1 (en) | 2017-03-09 |
Family
ID=58188254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2987919A Pending CA2987919A1 (en) | 2015-08-31 | 2016-08-31 | Fluorescence histo-tomography (fht) systems and methods |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3298383A4 (enExample) |
| JP (2) | JP6719123B2 (enExample) |
| KR (1) | KR20180048586A (enExample) |
| AU (1) | AU2016315795C1 (enExample) |
| CA (1) | CA2987919A1 (enExample) |
| WO (1) | WO2017040671A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10580130B2 (en) | 2017-03-24 | 2020-03-03 | Curadel, LLC | Tissue identification by an imaging system using color information |
| US10694117B2 (en) * | 2018-06-07 | 2020-06-23 | Curadel, LLC | Masking approach for imaging multi-peak fluorophores by an imaging system |
| KR102304036B1 (ko) * | 2019-11-27 | 2021-09-17 | 울산과학기술원 | 연속 블록면 광간섭 현미경 장치 |
| EP4105707A4 (en) | 2020-03-19 | 2023-08-23 | Sony Olympus Medical Solutions Inc. | MEDICAL OBSERVATION SYSTEM, CONTROL DEVICE AND CONTROL METHOD |
| US20220020481A1 (en) | 2020-07-20 | 2022-01-20 | Abbott Laboratories | Digital pass verification systems and methods |
| EP3964817B1 (en) | 2020-09-03 | 2023-01-04 | Inpeco SA | Device and method for the automatic insertion of a reference material during the processing of a biological sample |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10123054A (ja) * | 1996-10-23 | 1998-05-15 | Kagaku Gijutsu Shinko Jigyodan | 試料観察方法及びその装置 |
| WO2003016878A2 (de) * | 2001-08-09 | 2003-02-27 | Biocam Gmbh | System für die fluoreszenzdiagnostik |
| JP2006010620A (ja) * | 2004-06-29 | 2006-01-12 | Canon Inc | 顕微鏡観察用断面試料の作成方法、およびウルトラミクロトーム |
| US7507575B2 (en) * | 2005-04-01 | 2009-03-24 | 3M Innovative Properties Company | Multiplex fluorescence detection device having removable optical modules |
| DE102005045961B4 (de) * | 2005-09-26 | 2018-11-15 | Siemens Healthcare Gmbh | Verfahren und Vorrichtung zur Darstellung eines einen Fluoreszenzfarbstoff enthaltenden Gewebes |
| US7831075B2 (en) * | 2005-10-20 | 2010-11-09 | Case Western Reserve University | Imaging system |
| KR100853655B1 (ko) * | 2006-12-15 | 2008-08-25 | 한국전기연구원 | 피부 질환의 광학 진단 및 치료를 위한 장치, 광원 시스템 및 장치의 이용방법 |
| US20090236541A1 (en) * | 2008-03-24 | 2009-09-24 | General Electric Company | System and Methods for Optical Imaging |
| US8501435B2 (en) * | 2008-10-09 | 2013-08-06 | Sti Medical Systems, Llc | Process for preserving three dimensional orientation to allow registering histopathological diagnoses of tissue to images of that tissue |
| US8747331B2 (en) * | 2009-06-23 | 2014-06-10 | Hologic, Inc. | Variable angle guide holder for a biopsy guide plug |
| JP5564654B2 (ja) * | 2010-05-31 | 2014-07-30 | 岩崎電気株式会社 | Ｌｅｄ照射装置 |
| US20140135601A1 (en) * | 2012-11-09 | 2014-05-15 | Kestrel Labs, Inc. | User replaceable optical subsystem for laser-based photoplethysmography |
| CN105307687A (zh) * | 2013-03-15 | 2016-02-03 | 索隆-基特林癌症研究协会 | 多模态的基于二氧化硅的纳米粒子 |
| CN111329450A (zh) * | 2013-04-23 | 2020-06-26 | 雪松-西奈医学中心 | 用于从荧光团同时录制可见光图像和红外光图像的系统和方法 |
-
2016
- 2016-08-31 WO PCT/US2016/049708 patent/WO2017040671A1/en not_active Ceased
- 2016-08-31 KR KR1020187002483A patent/KR20180048586A/ko not_active Ceased
- 2016-08-31 AU AU2016315795A patent/AU2016315795C1/en active Active
- 2016-08-31 CA CA2987919A patent/CA2987919A1/en active Pending
- 2016-08-31 JP JP2018530666A patent/JP6719123B2/ja active Active
- 2016-08-31 EP EP16842910.8A patent/EP3298383A4/en not_active Withdrawn
-
2020
- 2020-06-08 JP JP2020099152A patent/JP7093086B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016315795C1 (en) | 2022-03-10 |
| EP3298383A4 (en) | 2019-01-16 |
| KR20180048586A (ko) | 2018-05-10 |
| EP3298383A1 (en) | 2018-03-28 |
| JP6719123B2 (ja) | 2020-07-08 |
| WO2017040671A1 (en) | 2017-03-09 |
| JP2018534584A (ja) | 2018-11-22 |
| JP2020169999A (ja) | 2020-10-15 |
| JP7093086B2 (ja) | 2022-06-29 |
| AU2016315795A1 (en) | 2017-12-14 |
| AU2016315795B2 (en) | 2021-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12292437B2 (en) | Fluorescence histo-tomography (FHT) systems and methods | |
| AU2016315795B2 (en) | Fluorescence histo-tomography (FHT) systems and methods | |
| EP3194937B1 (en) | Method for controlling depth of imaging in tissues using fluorescence microscopy under ultraviolet excitation following staining with fluorescing agents | |
| EP3298588B1 (en) | Multi-spectral three dimensional imaging system and method | |
| CA2595213A1 (en) | Method and apparatus for measuring cancerous changes from reflectance spectral measurements obtained during endoscopic imaging | |
| CA2732962A1 (en) | Dye application for confocal imaging of cellular microstructure | |
| Thong et al. | Toward real-time virtual biopsy of oral lesions using confocal laser endomicroscopy interfaced with embedded computing | |
| WO2012112911A2 (en) | Devices and methods for optical pathology | |
| Croce et al. | Human liver autofluorescence: an intrinsic tissue parameter discriminating normal and diseased conditions | |
| KR20200083512A (ko) | 수술 중의 외과적 마진 평가를 위한 이미징 방법 및 시스템 | |
| KR20210027255A (ko) | 광학 흡수 및 산란 매체 내 표면 형광 물체의 깊이를 결정하고 물체의 형광 농도를 결정하기 위한 장치 및 방법 | |
| US9854963B2 (en) | Apparatus and method for identifying one or more amyloid beta plaques in a plurality of discrete OCT retinal layers | |
| CN104181142A (zh) | 分子影像成像验证系统和方法 | |
| Jiang et al. | Calibration of fluorescence imaging for tumor surgical margin delineation: multistep registration of fluorescence and histological images | |
| Sarantopoulos et al. | Imaging the bio-distribution of molecular probes using multispectral cryoslicing imaging | |
| Byrd | Advancing fluorescent contrast agent recovery methods for surgical guidance applications | |
| CN204422419U (zh) | 分子影像成像验证系统 | |
| Razansky et al. | Optoacoustic Imaging of Adult Zebrafish |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210806 |
|
| EEER | Examination request |
Effective date: 20210806 |
|
| EEER | Examination request |
Effective date: 20210806 |
|
| EEER | Examination request |
Effective date: 20210806 |
|
| EEER | Examination request |
Effective date: 20210806 |
|
| EEER | Examination request |
Effective date: 20210806 |